Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy
- PMID: 17215265
- PMCID: PMC1955652
- DOI: 10.1136/bjo.2006.113118
Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy
Abstract
Background: It is difficult to assess the degree of optic nerve damage in patients with ethambutol-induced optic neuropathy, especially just after the onset of visual loss, when the optic disc typically looks normal.
Aim: To evaluate changes in retinal nerve fibre layer thickness (RNFLT) using optical coherence tomography (OCT) in patients with optic neuropathy within 3 months of cessation of ethambutol treatment.
Design: A retrospective observational case series from a single neuro-ophthalmology practice.
Methods: 8 patients with a history of ethambutol-induced optic neuropathy were examined within 3 months after stopping ethambutol treatment. All patients underwent a neuro-ophthalmologic examination, including visual acuity, colour vision, visual fields and funduscopy. OCT was performed on both eyes of each patient using the retinal nerve fibre layer analysis protocol.
Results: The interval between cessation of ethambutol treatment and the initial visit ranged from 1 week to 3 months. All patients had visual deficits characteristic of ethambutol-induced optic neuropathy at their initial visit, and the follow-up examination was performed within 12 months. Compared with the initial RNFLT, there was a statistically significant decrease in the mean RNFLT of the temporal, superior and nasal quadrants (p = 0.009, 0.019 and 0.025, respectively), with the greatest decrease in the temporal quadrant (mean decrease 26.5 mum).
Conclusions: A decrease in RNFLT is observed in all quadrants in patients with ethambutol-induced optic neuropathy who have recently discontinued the medication. This decrease is most pronounced in the temporal quadrant of the optic disc.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy.Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):410-6. doi: 10.1007/s00417-004-1053-1. Epub 2004 Nov 23. Graefes Arch Clin Exp Ophthalmol. 2005. PMID: 15565293
-
Follow-up of nonarteritic anterior ischemic optic neuropathy with optical coherence tomography.Ophthalmology. 2007 Dec;114(12):2338-44. doi: 10.1016/j.ophtha.2007.05.042. Epub 2007 Aug 27. Ophthalmology. 2007. PMID: 17719640
-
Optical coherence tomography can monitor reversible nerve-fibre layer changes in a patient with ethambutol-induced optic neuropathy.Br J Ophthalmol. 2007 Jun;91(6):839-40. doi: 10.1136/bjo.2006.107326. Br J Ophthalmol. 2007. PMID: 17510481 Free PMC article. No abstract available.
-
[New insights into the study of optic nerve diseases].Nippon Ganka Gakkai Zasshi. 2013 Mar;117(3):187-210; discussion 211. Nippon Ganka Gakkai Zasshi. 2013. PMID: 23631254 Review. Japanese.
-
Ethambutol-induced optic neuropathy: Functional and structural changes in the retina and optic nerve.Semin Ophthalmol. 2022 Aug;37(6):730-739. doi: 10.1080/08820538.2022.2085517. Epub 2022 Jun 14. Semin Ophthalmol. 2022. PMID: 35699333 Review.
Cited by
-
Evaluation of the Long-term Effect of Ethambutol Usage on the Retinal Nerve Fiber Layer Using Spectral-Domain Optical Coherence Tomography.Beyoglu Eye J. 2020 Jul 2;5(2):118-121. doi: 10.14744/bej.2020.96658. eCollection 2020. Beyoglu Eye J. 2020. PMID: 35098074 Free PMC article.
-
Clinical profile and visual outcomes in ethambutol-induced toxic optic neuropathy.Indian J Ophthalmol. 2025 Jun 1;73(Suppl 3):S484-S491. doi: 10.4103/IJO.IJO_1807_24. Epub 2025 May 30. Indian J Ophthalmol. 2025. PMID: 40444310 Free PMC article.
-
Are we pharmacovigilant enough in ophthalmic practice?Indian J Ophthalmol. 2013 May;61(5):226-9. doi: 10.4103/0301-4738.99847. Indian J Ophthalmol. 2013. PMID: 23571233 Free PMC article. Review.
-
The use of optical coherence tomography for the detection of ocular toxicity by ethambutol.PLoS One. 2018 Nov 8;13(11):e0204655. doi: 10.1371/journal.pone.0204655. eCollection 2018. PLoS One. 2018. PMID: 30408036 Free PMC article. Clinical Trial.
-
PKCδ-dependent signaling mediates ethambutol-induced toxic effects on human retinal pigment cells.Mol Vis. 2011;17:1564-76. Epub 2011 Jun 9. Mol Vis. 2011. PMID: 21738386 Free PMC article.
References
-
- Schild H S, Fox B C. Rapid‐onset reversible ocular toxicity from ethambutol therapy. Am J Med 199190404–406. - PubMed
-
- Zoumalan C I, Agarwal M, Sadun A A. Optical coherence tomography can measure axonal loss in patients with ethambutol‐induced optic neuropathy. Graefe's Arch Clin Exp Ophthalmol 2005243410–416. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical